Expand Smarter in the Drug And Gene Delivery Devices Market – With This 2025–2034 Forecast Report

 Unlock 30% off global market reports with code ONLINE30 — get insights on tariff changes, macro trends, and global economic shifts.

 

 How has the drug and gene delivery devices market size changed in recent years, and what is the outlook ahead?
 The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.61 $ billion in 2024 to $0.67 $ billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to healthcare infrastructure development, expansion of personalized gene therapy programs, increasing focus on preventive healthcare, rare and orphan diseases, and increasing public awareness about health and treatment options.
 
 The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $0.93 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, growing demand for personalized medicine, increasing awareness and adoption of gene therapy, demand for non-invasive and minimally invasive procedures, and the growing popularity of direct-to-patient delivery models. Major trends in the forecast period include advancements in biotechnology and genetic engineering, technological advancements in drug delivery systems, increasing investment in research and development, the development of novel delivery platforms, and advancements in diagnostic technologies.
 
 Download Your Free Sample PDF:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
 
 What are the top economic and technological drivers pushing drug and gene delivery devices market growth?
 The increasing adoption of gene therapy is expected to propel the growth of the drug and gene delivery devices market going forward. Gene therapy is a medical technique that involves the introduction, removal, or alteration of genetic material within a patient’s cells to treat or prevent disease. Gene therapy demand is rising due to its potential to cure genetic disorders and chronic diseases at their root causes, offering transformative treatment options where conventional therapies fall short. Drug and gene delivery devices are essential in gene therapy for precise targeting and controlled release of therapeutic genes, enhancing treatment efficacy. For instance, in November 2023, according to the National Centre for Biotechnology Information, a US-based resource for the scientific research community, the expected number of new patients treated with gene therapies will grow from 16,244 in 2020 to 94,696 in 2025. Therefore, the increasing adoption of gene therapy is driving the growth of the drug and gene delivery devices market.
 
 How is the drug and gene delivery devices market segmented by product, application, and end-user?
 The drug and gene delivery devicesmarket covered in this report is segmented — 
 
 1) By Vector: Viral, Non-viral
 2) By Method: In Situ, Ex Vivo
 3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
 
 Subsegments:
 1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors 
 2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
 
 View The Full Market Report:
 https://www.thebusinessresearchcompany.com/report/drug-and-gene-delivery-devices-global-market-report
 
 Which sustainability trends are emerging in the drug and gene delivery devices market?
 Major companies operating in the drug and gene delivery devices market are focusing on developing advanced products, such as artificial intelligence (AI) technology, to gain a competitive edge in the market. Artificial intelligence (AI) technology in drug delivery refers to the application of AI techniques and algorithms to improve the efficiency, precision, and effectiveness of drug delivery systems. For instance, in December 2023, Envoya Inc., a US-based developer of polymer-based nanoparticles for targeted delivery, launched an innovative gene therapy drug delivery platform. This platform combines biopolymer-nanoparticles with artificial intelligence (AI) to address significant limitations in current gene therapy technologies, such as viral vectors and lipid nanoparticles. The platform aims to overcome the limitations of existing gene therapy delivery technologies, which have been restricted by safety concerns, limited payload capacities, and limited tissue targeting.
 
 Which leading companies are dominating the drug and gene delivery devices market landscape?
 Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics 
 
 Which geographic areas are expected to offer the highest growth opportunities in thedrug and gene delivery devices market?
 North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 How Can Companies Use The Drug And Gene Delivery Devices Market Report to Drive Business Results?
 This report provides actionable insights tailored for business use — not academic analysis. Companies can leverage the data to:
 • Time market entry or expansion using growth forecasts and CAGR trends.
 • Develop competitive products by tracking key technology shifts and user preferences.
 • Tailor regional strategies with in-depth geographic data and local market dynamics.
 • Benchmark and plan partnerships using competitive landscape insights.
 
 Purchase The Report And Get A Swift Delivery:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404
 
 Need Customized Data On Drug And Gene Delivery Devices Market?
 For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
 
 Request Customized Data:
 https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. 
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making. 
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496-7795
 Europe +44 7882 955267
 Asia & Others +44 7882 955267 & +91 8897263534
 Email us at info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company